Biotechnology is a global industry, but the Connecticut town of Branford is well positioned to play a prominent role in its future, a group of industry executives said in a forum held recently at the town’s James Blackstone Memorial Library.

“What’s going on in Connecticut today in places like Branford, Farmington, New London and New Haven is the basis for a future that leads or plays a significant role in the a biotechnology revolution,” said Mike Hyde, vice president for external affairs and strategic partnerships at Jackson Laboratory.

Branford’s most recent coup was landing the Icahn School of Medicine at Mount Sinai, which opened in October a state-of-the-art genomics research facility on Commercial Street. Startups like Pfizer spinoff Durata, and neurological disease researcher Axerion Therapeutics are among the dozens of bioscience companies that call Branford home.

article in the New Haven Register
article in Hartford Business